Topic: academic partnership
There’s no one-size-fits-all solution when it comes to academic partnerships, but successful ones have one thing in common: communication.
Three cancer charities will pour over $39 million into six U.K. and European research projects, to provide for a post-Brexit collaboration model.
Eli Lilly doubles down on its collaboration with the Dana-Farber Cancer Institute, extending the partnership for another three years.
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming with two Seattle-based academic centers.
Pfizer has set up a new partnering network to try to foster collaborations with top-tier universities
Novartis and UC Berkeley have formed a pact to unlock difficult drug targets and boost development of new meds in infectious diseases and cancer.
Australian scientists have found a natural compound in seaweed that can halt inflammation after traumatic brain injury.
Erytech Pharma has formed a collaboration with Canada’s Queen’s University to advance its drug against the metabolic disorder arginase-1 deficiency.
Lilly and Purdue University have teamed up to work on a new research collaboration.
Merck KGaA has taken its oncology collaboration with Cancer Research Technology to the next level.